Loading clinical trials...
Loading clinical trials...
Reducing Veterans' Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing
Conditions
Interventions
Pharmacogenetic and polygenic risk testing
Active control
Locations
2
United States
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Indianapolis, Indiana, United States
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States
Start Date
April 1, 2025
Primary Completion Date
May 31, 2027
Completion Date
July 28, 2028
Last Updated
April 13, 2026
NCT07473960
NCT00353782
NCT07489209
NCT07037771
NCT07058077
NCT06555120
Lead Sponsor
VA Office of Research and Development
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions